Borr Drilling BORR
Three insiders bought $49.7M over 30 days, within the 30-day window
Last open-market buy
- Tor Olav Troim $48M
- Harvey Edward Snowling $1.5M
- De Oliveira Bruno Morand $200K
Source: Form 4 filings on SEC EDGAR
Type a ticker for one company's Form 4s, or read today's open-market trades at companies with a public float under $300M (All companies is one tap away): buys first, then sales, cluster buys and each insider's record across companies.
6 of 15 companies whose last cluster buy was in the last 30 days, those with a public float under $2B first.
Three insiders bought $49.7M over 30 days, within the 30-day window
Last open-market buy
Three insiders bought $42.7M over 21 days, within the 30-day window
Last open-market buy
Four insiders bought $1.8M over 6 days, within the 30-day window
Last open-market buy
Six insiders bought $1.7M over 3 days, within the 30-day window
Last open-market buy
Five insiders bought $461K over 4 days, within the 30-day window
Last open-market buy
Four insiders bought $295K over 26 days, within the 30-day window
Last open-market buy
Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. The Stake column is the change in their holding.
| Traded | Company | Insider | Trade | Value | Stake | Notes |
|---|---|---|---|---|---|---|
| Nov 2, 2026 Filed Nov 3, 2026 | Caterpillar CAT | James C Fish Jr Director | Open-market buy 1,000 shares | $620K at $620.39 | +27% | Their first open-market buy here in SEC Tracker's records. 4 days after the company's 8-K filed Oct 29, 2026. |
| Oct 30, 2026 Filed Nov 3, 2026 | Alamar Biosciences ALMR | Qiming Corporate GP VI 10% owner | Open-market sale 48,659 shares | $1.5M at $29.93 | −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. |
| Oct 30, 2026 Filed Nov 3, 2026 | Alamar Biosciences ALMR | Qiming Corporate GP VI 10% owner | Open-market sale 40,112 shares | $1.2M at $30.70 | −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. |
| Nov 2, 2026 Filed Nov 3, 2026 | Alamar Biosciences ALMR | Qiming Corporate GP VI 10% owner | Open-market sale 28,404 shares | $848K at $29.84 | −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 19 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. |
| Oct 30, 2026 Filed Nov 3, 2026 | Alamar Biosciences ALMR | Qiming Corporate GP VI 10% owner | Open-market sale 13,593 shares | $407K at $29.93 | −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. |
| Oct 30, 2026 Filed Nov 3, 2026 | Alamar Biosciences ALMR | Qiming Corporate GP VI 10% owner | Open-market sale 11,205 shares | $344K at $30.70 | −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. |
| Oct 30, 2026 Filed Nov 3, 2026 | Alamar Biosciences ALMR | Qiming Corporate GP VI 10% owner | Open-market sale 11,354 shares | $340K at $29.93 | −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. |
| Oct 30, 2026 Filed Nov 3, 2026 | Alamar Biosciences ALMR | Qiming Corporate GP VI 10% owner | Open-market sale 9,359 shares | $287K at $30.70 | −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. |
| Nov 2, 2026 Filed Nov 3, 2026 | Alamar Biosciences ALMR | Qiming Corporate GP VI 10% owner | Open-market sale 7,935 shares | $237K at $29.84 | −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 19 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. |
| Nov 2, 2026 Filed Nov 3, 2026 | Alamar Biosciences ALMR | Qiming Corporate GP VI 10% owner | Open-market sale 6,628 shares | $198K at $29.84 | −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 19 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. |
| Oct 30, 2026 Filed Nov 3, 2026 | Alamar Biosciences ALMR | Qiming Corporate GP VI 10% owner | Open-market sale 3,400 shares | $109K at $31.96 | −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026. |
8 open-market sales at companies with a public float of $2B or more are under Everything.
The 3 insiders in these trades with the most bought and sold on the open market across every company, in SEC Tracker's records.
| Insider | Buys | Sales | Bought | Sold | Companies |
|---|---|---|---|---|---|
| Qiming Corporate GP VI | 0 | 116 | $41.2M | 1 | |
| John K Stipancich | 1 | 80 | $32K | $21.8M | 3 |
| James C Fish Jr | 1 | 0 | $620K | 1 |
Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.